Literature DB >> 21883875

Brazilian Portuguese validation of the Leeds Assessment of Neuropathic Symptoms and Signs for patients with chronic pain.

Pedro Schestatsky1, Vitor Félix-Torres, Márcia Lorena Fagundes Chaves, Betânia Câmara-Ehlers, Tamara Mucenic, Wolnei Caumo, Osvaldo Nascimento, Michael I Bennett.   

Abstract

BACKGROUND: Neuropathic pain (NP) is a very frequent and unrecognized condition in clinical practice. Therefore, it is important to have a reliable instrument to assess pain subtypes in various cultures. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) has been widely used and validated in many countries. Up to now, there has been no reliability study of this instrument in Brazil.
METHODS: The scores of the Brazilian Portuguese version of the LANSS were studied in a sample of 90 chronic pain outpatients from southern Brazil. LANSS was translated into Portuguese and then back translated to English. Intraclass correlation coefficient (ICC) and internal consistency (IC) were estimated. The intensity of pain complaints, other demographic data, and LANSS scores distribution according to pain subtypes (nociceptive, neuropathic, and mixed) were also evaluated.
RESULTS: The Brazilian Portuguese version of the LANSS showed good ICC (r = 0.97) and IC (Cronbach's α = 0.67 for total LANSS score). Patients with NP provided significant higher LANSS scores (19.1 ± 3.3) in comparison with those with nociceptive (7.3 ± 4.5) and mixed (13.9 ± 3.7) types of pain.
CONCLUSIONS: This LANSS version was found to be a reliable instrument for the evaluation of pain complaints due to a variety of causes. The profile of pain scores was similar to that observed in other countries. Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21883875     DOI: 10.1111/j.1526-4637.2011.01221.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  6 in total

1.  A Brazilian randomized study: Robotic-Assisted vs. Video-assisted lung lobectomy Outcomes (BRAVO trial).

Authors:  Ricardo Mingarini Terra; Pedro Henrique Xavier Nabuco de Araujo; Leticia Leone Lauricella; Jose Ribas Milanese de Campos; Juliana Rocha Mol Trindade; Paulo Manuel Pêgo-Fernandes
Journal:  J Bras Pneumol       Date:  2022-07-08       Impact factor: 2.800

2.  Can the LANSS scale be used to classify pain in chronic cancer pain trials?

Authors:  Janet Hardy; Stephen Quinn; Belinda Fazekas; Meera Agar; David Currow
Journal:  Support Care Cancer       Date:  2013-08-10       Impact factor: 3.603

3.  Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.

Authors:  Cholhee Park; Youn-Woo Lee; Duck Mi Yoon; Do Wan Kim; Da Jeong Nam; Do-Hyeong Kim
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

4.  Comparison of pain burden and psychological factors in Brazilian women living with HIV and chronic neuropathic or nociceptive pain: An exploratory study.

Authors:  Andressa de Souza; Wolnei Caumo; Prisla Ucker Calvetti; Rachel Nunes Lorenzoni; Gisele Keller da Rosa; Alexandre Ramos Lazzarotto; Jairo Alberto Dussan-Sarria
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.240

5.  Dental approach of orofacial pain in head and neck cancer patients.

Authors:  Diele Arantes; Náira Costa; Tacyana Resende; Karina Mikulas; Pierre da Silva Júnior; Rafael Brito; Vladimir Noronha; Roberto Pedras; Luciana Corrêa
Journal:  J Clin Exp Dent       Date:  2018-11-01

6.  Distress and Spiritual Well-Being in Brazilian Patients Initiating Chemotherapy during the COVID-19 Pandemic-A Cross-Sectional Study.

Authors:  Angelo Braga Mendonça; Eliane Ramos Pereira; Carinne Magnago; Pedro Gilson da Silva; Diva Cristina Morett Leão; Rose Mary Costa Rosa Andrade Silva; Karina Cardoso Meira
Journal:  Int J Environ Res Public Health       Date:  2021-12-15       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.